Similar Posts
Dixon Tech shares soar 5% after Q3. Should you buy, sell, or hold?
Shares of electronics contract manufacturer Dixon Technologies gained as much as 5% to their day’s high of Rs 10,846 on BSE on Friday after its net profit rose 67% YoY to Rs 287 crore, largely supported by a one-time gain of Rs 131 crore from the fair value adjustment related to Dixon’s stake sale in…
Market Speculator Part-Time | Swing Trade Report
Oops! You don’t have access to this content. In order to view it you must purchase the subscription. For more information contact us on the Live Chat. Username or E-mail Password Remember Me Forgot Password The post Market Speculator Part-Time | Swing Trade Report appeared first on Bulls on Wall Street. Source link
VantagePoint A.I. Stock of the Week Electronic Arts ($EA) – VantagePoint $WDC
This week’s ai stock spotlight is Electronic Arts ($EA) Electronic Arts ($EA) is a publicly traded powerhouse headquartered in Redwood City, California, founded in 1982 by Trip Hawkins. From its origins in the personal computing boom, EA has evolved into one of the largest global publishers of interactive entertainment. The company’s fiscal 2024 net revenue…
Capitol Farce – Fat Tail Daily
The Primary Trend is not determined by what people want or what they expect. Instead, they get what they deserve, shaped by patterns of history rather than the conscious efforts of those who live it. ‘Don’t f*** around with Medicaid…’ –Donald Trump to House Republicans We remind readers that we do not take sides…nor do…
Maple Leaf Foods Inc
Sound bite for Twitter and StockTwits is: Dividend Growth Consumer. Results of stock price testing is that the stock price is probably cheap. Debt Ratios are fine and better currently than for 2023. The Dividend Payout Ratios (DPR) are too high because of recent earnings losses and low cash flow, but analysts expect this to…
Zydus Lifesciences to raise Rs 5,000 cr via equity; Q2 profit up 38%
Zydus Lifesciences’ board on Thursday approved a proposal to raise up to Rs 5,000 crore through a share sale, which the pharmaceutical company said will help strengthen its balance sheet by reducing debt and fuel future growth. The fundraising may be executed in one or more tranches through a public or private sale of shares…


